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Treatment of drug-resistant forms of tuberculosis, characterized by the rapid 
multiplication of MBT, massive infiltrative-caseous changes in the lungs, 
numerous destructions of lung tissue, severe intoxication syndrome, causes 
considerable difficulties. 
One of the main reasons for the lack of efficacy of treatment of this group of 
patients is adverse side effects that arise during combination therapy of anti-TB 
drugs. They significantly limit the ability of chemotherapy and reduce the 
effectiveness of treatment of pulmonary tuberculosis in basic indicators – the terms 
of cessation of bacterial excretion and frequency of cavities closure [1, 2]. 
Despite the extensive experience of anti-TB drugs usage, the problem of 
their side effects on a microorganism remains relevant even today. Since the pre-
clinical and clinical trials can not reveal the whole spectrum of possible adverse 
side reactions to drugs, the need for further research and evaluation of unwanted 
effects to medication and putting them into practice is rather obvious [3].  
The objective of the scientific work is considering the lack of effective 
treatment of these patients, one of the reasons for which is the mal-absorption of 
drugs in the intestine, to define the prevalence and nature of digestive system 
lesions, depending on the profile of resistance to anti-TB medication; to identify 
the main side effects caused by various anti-TB drugs, which are more common in 
the region and the ways to improve the pharmacological correction of metabolic 
changes in individual units, depending on the functional state of the digestive 
system. 
The results of the research. The object of the study were 112 patients with 
newly diagnosed pulmonary drug-resistant TB and 22 patients with preserved 
resistance of Mycobacterium tuberculosis to anti-TB drugs, who were treated in 
the hospitals of the 1st and 2nd phtisiatric departments of Chernivtsi Region 
Tuberculosis Dispensary (OTD) and 20 patients with drug-resistant tuberculosis of 
the Communal City Institution TB Dispensary, whose anti-TB drugs intolerance 
has been studied during the period of  2012-2013. The diagnostics of TB and 
determining the degree of activity of specific inflammatory process were applied 
on the basis of complex clinical, laboratory, radiological and bronchological data. 
For comparison, 21 healthy volunteers were studied by the same parameters in the 
control group. 
The results obtained have been processed by the conventional methods using 
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Student’s criterion of distinction and applications software package Microsoft 
Office-XP, Statistica 6.0 (StatSoft ™). 
The group of patients under examination was divided according to their ages 
as follows: young people (20 to 45 years old) accounted for 46,3%, middle-aged 
individuals (45 to 59 years old) – 39%, senior people (60 to 74 ) – 7,3%, elderly 
patients (75 to 89)  – 7,3%. 
The average age of patients was (41,9±1,8). Men predominated – 31 
(72,1%). 
The patients under examination complained mainly of persistent cough with 
sputum, fever (37,4 - 38,9ºC), periodic shortness of breath, weight loss, general 
weakness. 54,9% of the patients were in a satisfactory general condition, 36,1% - 
in a moderate one, and only 9% - in a heavy. 
According to the objective research methods the indicators of heart rate, 
blood pressure and respiratory rate fluctuated within the normal range and 
subsequently varied depending on the individual tolerance to chemotherapy. 
During percussion a clear lung sound prevailed, 20,9% of patients produced a 
bandbox lung sound (which is a sign of compensatory emphysema) and 16,2% - a 
drum-like tympanic sound, because of large cavities. Through auscultatory 
percussion 83,7% of patients demonstrated mostly even weakened vesicular 
breathing, 16,3% - with bronchial component. 72,1% of the surveyed patients had 
variegated moist crepitant rales over the affected areas of the lungs. 
In 78,9% of patients, tuberculosis process was characterized by the presence 
of multiple destruction (more than two), massive focal , infiltrative and 
pneumosclerotic changes in both lungs which go beyond one lobe, complaints of 
breast pain and severe intoxication syndrome (cough, dyspnoea, febrile 
temperature increase of the number of red blood cells and neutrophil granulocytes, 
and erythrocyte sedimentation rate ). 
Allocating by the forms of the disease the largest group of patients with 
disseminated pulmonary tuberculosis represented 65,1%. Infiltrative tuberculosis 
was diagnosed among 34,9% of patients. 
We analyzed the data on the sensitivity of MBT to anti-TB drugs of the first 
and second line in Chernivtsi region in 112 patients who were treated in the second 
phthisiatric department of the regional anti-tuberculosis dispensary. It was proved 
that 60 (53,6%) patients had multi-resistance, including: 9 (8%) - to HR, 22 
(19,6%) - to HRS, 20 (17,8%) - to HRSE, 3 (2,7%) - to HRE, other 5,4% of 
patients demonstrate resistance to the following combinations of drugs: HRSEt – 
1,8% of patients, HRSZ, HRSKmEt, HRSKmECm, HRSEEt – 0,9% to each 
combination. In 24 (21,4%) patients, MBT mono-resistance was diagnosed: 4 
(3,6%) - isoniazid , 5 (4,5%) - rifampicin , 11 (9,8%) – streptomycin, 1 (0,9%) - to 
ethambutol, 2 (1,8%) - to Ethionamidum, 1 (0,9 %) - to amikacin. MBT poly-
resistance was diagnosed in 27 (24,1%) patients. The most common 
Mycobacterium tuberculosis was resistant to a combination of HS (10,7% of 
patients), much less - to HSE and HEt (2,7% each), to SE – 0,4% and to HSEEt – 
1,8% of patients to each combination, to HE, HSKmEt, HSEt, SEt – 0,9% each. 
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Enhanced resistance of Mycobacterium tuberculosis was diagnosed in 0,9% of 
patients. 
The development of adverse side effects during the full chemotherapy 
course for patients with drug-resistant tuberculosis occurs mainly in the first weeks 
of the intensive phase of treatment. Analysis of the rate of frequency of adverse 
reactions to anti-TB drugs was carried out among 132 patients with drug-resistant 
tuberculosis who were treated in the second phthisiatric department of Oblast 
Tuberculosis Dispensary and Communal City Institution TB Dispensary; it 
amounts for 15,2% of the whole number of patients. In 8 % of cases they had to 
completely withdraw from the further use of anti-tuberculosis drugs that cause side 
effects. 
Analyzing the data of clinical, laboratory tests and ultrasound research of the 
abdominal organs by 20 patients with drug-resistant tuberculosis, it appears that 
disruption of the digestive system, mainly by the hepato-pancreato-biliary system 
in the form of diffuse liver changes, sometimes increasing it, as well as signs of 
cholecystopancreatitis occur in patients with mono-resistance - 41%, among 
patients with multi-resistance in 72 % of cases, with poly-resistance - almost 90 % 
and all the patients with advanced Mycobacterium tuberculosis resistance. 
The study of anti-mycobacterial drugs intolerance showed that among the 
first- and second-line anti-tuberculosis medications most common side effects 
occur when taking prothionamide - 30% of patients who complain of nausea, 
dizziness, abdominal pain, tachycardia, and application of kanamycin - 25% of 
patients noticed deterioration of hearing and tinnitus. 10% of patients while taking 
levofloxacin noted arthralgia, myalgia, nausea and dizziness. 15% of patients 
receiving pyrazinamide, ethambutol and gatifloxacin observed allergic reactions 
such as skin rashes and itch. Other 15% experienced gastrointestinal disorders – 
diarrhea, nausea, vomiting while taking ofloxacin, coxerin and teriz. With 5% 
taking closerin an epileptic attack was observed. 
We have selected 59 patients with newly diagnosed destructive pulmonary 
tuberculosis, which demonstrated changes in hepato-pancreato-biliary system, 20 
of which had drug-resistant tuberculosis. They made up the first examination 
group, the 2nd group consisted of patients with preserved sensitivity of MBT, and 
the 3d group consisted of 22 patients with pulmonary drug-resistant tuberculosis, 
who did not reveal disorders of the digestive system. Control group consisted of 21 
healthy volunteers (normal subjects). 
Most of the examined patients of groups 2 and 3 (57,5% of cases) revealed 
moderate intoxication syndrome, as evidenced mainly by febrile body temperature, 
complaints of general weakness, fatigue, sudden weight loss, lack of appetite, 
changes in clinical blood: leukocytosis, shift in leukocyte formula , ESR 
(erythrocyte sedimentation rate) acceleration and expressed catarrhal phenomena 
in the lungs. X-raying all patients revealed the destruction of the lungs (1 to 3 
lesion areas), infiltrative, focal changes of varying prevalence. For a more 
complete description of the severity of the disease, we determined the number of 
index indicators - leukocytic intoxication index, hematological intoxication index, 
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the index of leukocytes shift, lymphocytic index and allergization index. Patients 
with drug-resistant pulmonary tuberculosis with disorders in the hepato-pancreato-
biliary system note an increase in all the index parameters in comparison with 
other groups and an average of 15 % higher than indicators of healthy people. 
These patients develop leukocytosis by increasing the relative number of 
eosinophils and stab neutrophils, there is a significant decrease in the relative 
number of peripheral blood monocytes. 
The reduction of lymphocytic index is a direct sign of the presence of 
endotoxemia in groups 1-3 in one way or another. Leukopenia and decrease in 
ESR leads to reduced hematological toxicity index and reflects intoxication as a 
stage of endotoxemia. In the examined groups leukocytosis and increased 
erythrocyte sedimentation rate and hence increase of HTI were observed, which 
indicates that there is an intoxication beyond the interstitial space and demonstrates 
endotoxemia on the peripheral blood level. The biggest divergence of LII and HTI 
was observed in group 1, indicating a higher severity of endotoxemia (HTI exceeds 
LII). 
The probability differences are marked: p - compared with control group, n - 
number of observations 
The analysis of the results of the study also suggests that the severity of 
endogenous intoxication does not depend on the clinical forms of tuberculous 
processes in the lungs. When comparing the results obtained in the case of 
infiltrative and disseminated forms no possible difference of indicators was 
observed. 
It should also be noted that toxicity indicators are constantly increasing with 
the severity of a form of pulmonary tuberculosis. Leukocytic intoxication index is 
the most sensitive in relation to evaluation of the severity of endogenous 
intoxication among all the examined groups of patients in our research. 
Conclusions: 
Among patients with drug-resistant tuberculosis in Chernivtsi region the 
most frequent is multi-resistance (resistance mainly to combinations of drugs - 
HRS and HRSE), MBT resistance to HS and streptomycin. Therefore, in order to 
reduce the prevalence of drug-resistant TB one should carefully follow the new 
standards of anti-mycobacterial therapy and improve medication management in 
the administrative areas, providing supply of medicines and their efficient use. 
The incidence of adverse reactions to anti-TB drugs is 15,2% of the general 
number of patients. Hepato-pancreato-biliary system disorders occur in 41% of 
patients with mono-resistance, 72% - with multi-resistance, almost 90% - with 
poly-resistance and all patients with advanced resistance of Mycobacterium 
tuberculosis. 
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